Home › Funds › VISTA FINANCE, LLC › LGND

VISTA FINANCE, LLC position in LGND

LIGAND PHARMACEUTICALS INC · Health Care

VISTA FINANCE, LLC reported holding 831 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$260K, representing 0.14% of its reported portfolio and ranking #40 among its reported holdings. VISTA FINANCE, LLC has disclosed LGND holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

Latest position (Q3 2026)831 sh
Reported value held$259.58K
Portfolio Weight0.14%
First reportedQ2 2026
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How VISTA FINANCE, LLC's LGND position evolved

VISTA FINANCE, LLC first disclosed a stake in LGND in Q2 2026 at 882 shares (US$279K). Across 2 filings, VISTA FINANCE, LLC increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 831 shares valued at US$260K — a reduction of -51 shares quarter over quarter..

Quarter by quarter

QuarterSharesValueChange
Q2 2026 882 $278.79K New
Q3 2026 831 $259.58K Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About LGND and 13F data

LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 52 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding LGND

All LGND fund holders →

FAQ

How long has VISTA FINANCE, LLC held LGND?

VISTA FINANCE, LLC has disclosed LGND holdings in 2 of the last 2 reported quarters, going back to Q2 2026.

What is VISTA FINANCE, LLC's current position in LGND?

As of Q3 2026, VISTA FINANCE, LLC holds 831 shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $259.58K, representing 0.14% of its reported portfolio and ranking #40.

Has VISTA FINANCE, LLC been buying or selling LGND?

In the latest 13F filing (Q3 2026), VISTA FINANCE, LLC reduced its position in LGND.

Which other funds hold LGND?

Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 52 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.